OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1
Xuetao Li, Guangliang Chen, Bin Liu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives
Youming Chen, Zuli Jiang, Ying Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126773-126773
Closed Access | Times Cited: 23

Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential
Ngoc Thi Minh Dinh, Tuan Minh Nguyen, Mi Kyung Park, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 717-717
Open Access | Times Cited: 13

V-ATPase in glioma stem cells: a novel metabolic vulnerability
Alessandra Maria Storaci, Irene Bertolini, Cristina Martelli, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

Polypeptide nanomicelles co-deliver PLK1 and BCL-2/xL inhibitors for synergetic therapy of brain tumor
Yueyue Zhang, Xiaofei Zhao, Xin Wang, et al.
Nano Today (2025) Vol. 62, pp. 102712-102712
Closed Access

Apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) promotes stress granule formation via YBX1 phosphorylation in ovarian cancer
Shuyu Mao, Chong Xie, Yufeng Liu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3

Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers
Yufei Wang, Guihua Wang, Wei Xiang, et al.
European Journal of Pharmacology (2024) Vol. 972, pp. 176558-176558
Closed Access | Times Cited: 3

PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti‐tumor effects
Poyil Pratheeshkumar, Abdul K. Siraj, Divya Padmaja, et al.
Molecular Oncology (2024) Vol. 18, Iss. 3, pp. 691-706
Open Access | Times Cited: 2

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis
Yun Fang, Na Wu, Xiaojia Yi, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 1

Polo-Like Kinase 1 Predicts Lymph Node Metastasis in Middle Eastern Colorectal Cancer Patients; Its Inhibition Reverses 5-Fu Resistance in Colorectal Cancer Cells
Poyil Pratheeshkumar, Abdul K. Siraj, Divya Padmaja, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1700-1700
Open Access | Times Cited: 1

YBX1: A Multifunctional Protein in Senescence and Immune Regulation
Wenze Zhang, Ying Liu, Zhe Zhao, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14058-14079
Open Access | Times Cited: 1

PLK1 inhibition impairs erythroid differentiation
Peijun Jia, Zhiyong Li, Lulu Duan, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis
chun Zhu, Yun Fang, Na Wu, et al.
Research Square (Research Square) (2024)
Open Access

Mapping Glioma Progression: Single-Cell RNA Sequencing Illuminates Cell-Cell Interactions and Immune Response Variability
Xia Li, Shenbo Chen, Ming Ding, et al.
Research Square (Research Square) (2024)
Closed Access

YB1 and its role in osteosarcoma: a review
Fan Wu, Dapeng Li
Frontiers in Oncology (2024) Vol. 14
Open Access

Page 1

Scroll to top